Patents by Inventor Brent K. Blackburn

Brent K. Blackburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted alkyl piperazine derivatives
    Publication number: 20010047001
    Abstract: Novel compounds of the general formula: 1
    Type: Application
    Filed: February 22, 2001
    Publication date: November 29, 2001
    Inventors: Vaibhav Varkhedkar, Venkata P. Palle, Jeff Zablocki, Elfatih Elzein, Brent K. Blackburn
  • Substituted piperazine compounds
    Publication number: 20010044541
    Abstract: Novel compounds of the general formula: 1
    Type: Application
    Filed: February 22, 2001
    Publication date: November 22, 2001
    Inventors: Brent K. Blackburn, Jeff Zablocki, Elfatih Elzein, Grigory Nudelman
  • Aralkyl substituted piperazine compounds
    Publication number: 20010041704
    Abstract: Novel compounds of the general formula: 1
    Type: Application
    Filed: February 22, 2001
    Publication date: November 15, 2001
    Inventors: Jeff Zablocki, Elfatih Elzein, Brent K. Blackburn, Tim Marquart, Prabha N. Ibrahim, Venkata P. Palle
  • Tricyclic inhibitors of the vitronectin receptor
    Patent number: 5716951
    Abstract: A tricylic benzodiazepine derivative that acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: February 10, 1998
    Assignee: Genentech, Inc.
    Inventors: Brent K. Blackburn, Kirk Robarge, Todd C. Somers
  • Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor
    Patent number: 5705890
    Abstract: A tricylic benzodiazepine derivative that acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
    Type: Grant
    Filed: September 26, 1994
    Date of Patent: January 6, 1998
    Assignee: Genentech, Inc.
    Inventors: Brent K. Blackburn, Kirk Robarge, Todd C. Somers
  • Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor
    Patent number: 5493020
    Abstract: A trycylic benzodiazepine derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
    Type: Grant
    Filed: July 29, 1993
    Date of Patent: February 20, 1996
    Assignee: Genentech, Inc.
    Inventors: Brent K. Blackburn, Kirk Robarge, Todd C. Somers